Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.
Clarity Pharmaceuticals Ltd has announced the appointment of Michelle Parker as a Director on September 20, 2024, along with her initial interests in the company which includes 535,000 ordinary shares and various options exercisable between December 2024 and July 2029. There are no disclosed interests in securities where Parker is not the registered holder, nor any interests in contracts as per the initial director’s interest notice.
For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.